Globus Medical GMED said Thursday it will pay 0.75 a share of its stock for each share of NuVasive NUVA stock in a deal that values NuVasive at about $3.1 billion or $57.72 a share. Globus Medical stock is down 12% in premarket trades, while NuVasive stock is rallying 11.9%. The companies said the deal will combine “two well-regarded technology companies in the musculoskeletal industry, which have a shared vision focused on innovation.
75 a share of its stock for each share of NuVasive NUVA stock in a deal that values NuVasive at about $3.1 billion or $57.72 a share. Globus Medical stock is down 12% in premarket trades, while NuVasive stock is rallying 11.9%. The companies said the deal will combine “two well-regarded technology companies in the musculoskeletal industry, which have a shared vision focused on innovation.